Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bioplus Acquisition Corp Cl A
(NQ:
BIOS
)
N/A
UNCHANGED
Last Price
Updated: 3:46 PM EDT, Oct 6, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
10.70 (3)
Ask (Size)
10.80 (3)
Prev. Close
10.79
Today's Range
N/A - N/A
52wk Range
10.71 - 10.84
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
October 04, 2023
From
Avertix Medical Inc.
Via
GlobeNewswire
BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
October 04, 2023
From
BioPlus Acquisition Corp.
Via
GlobeNewswire
Performance
More News
Read More
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
August 16, 2023
From
Avertix Medical Inc.
Via
GlobeNewswire
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors
July 17, 2023
From
Avertix Medical Inc.
Via
GlobeNewswire
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
June 13, 2023
From
Avertix Medical Inc.
Via
GlobeNewswire
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
May 03, 2023
From
Avertix Medical Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.